Even for experienced clinicians, unfamiliar organisms, unusual resistance patterns, or ambiguous comments can require clarification. Understanding what each element of the report means, where the information comes from, and what the clinical implications are is a genuinely transferable skill that improves prescribing decisions, infection management, and communication with microbiology teams.
This page works through the structure of a typical clinical microbiology report section by section: specimen details, Gram stain results, culture results, identification, susceptibility panels, and interpretive comments. It explains what each element means in plain language and what clinical decisions each element should inform.
The Specimen Details Section
Every report starts with specimen information: patient identifier, ward or location, requesting clinician, specimen type, collection date and time, received date and time. These details matter more than they might appear.
Collection time matters for blood cultures (time to positivity is calculated from the collection time), for urine cultures (a sample collected very early in the morning may have concentrated overnight, affecting colony counts), and for wound swabs (long transport time in a non-refrigerated specimen can allow overgrowth of robust organisms and die-off of fastidious ones).
Specimen type defines what the result means. A "wound swab from right heel" means the interpretation needs to account for surface colonisation and the Levine technique. A "biopsy tissue, left hip prosthesis" means the organisms identified are much more likely to be true pathogens. A "first-catch urine" for STI testing is completely different from a midstream urine for UTI culture.
The Gram Stain
The Gram stain result is reported as part of the preliminary result and is usually available within hours of the sample arriving in the laboratory, before any culture growth is detected.
A typical Gram stain report format: "Gram stain: Numerous polymorphonuclear leucocytes. Gram-positive cocci in clusters."
"Numerous polymorphonuclear leucocytes (PMNLs)" means there are many neutrophils visible in the sample. This is a strong indicator that the sample came from an actively inflamed site and supports a diagnosis of infection rather than colonisation. The white blood cell count on the Gram stain is just as important as the organism.
"Gram-positive cocci in clusters" points to Staphylococcus. Pairs and chains suggest Streptococcus or Enterococcus. Large gram-positive rods suggest Bacillus or Clostridium. Small gram-negative rods suggest Enterobacteriaceae or Haemophilus. Gram-negative diplococci suggest Neisseria.
"Mixed flora" on Gram stain means multiple different morphological types of organisms are visible, consistent with polymicrobial flora typical of colonisation or contamination.
"No organisms seen" does not mean the sample is sterile: the sensitivity of Gram stain for detecting organisms is approximately 10^5 organisms/mL. Below this density, bacteria may be present but not visible.
The Culture Result
Culture results identify the organism(s) grown and provide a semi-quantitative or quantitative estimate of their abundance.
Semi-quantitative growth: reported as "Scanty," "Light," "+," "++" or "Sparse," "Moderate," "Heavy" growth. These reflect the number of colonies observed on primary culture plates. Scanty/sparse growth from a wound swab often represents colonisation. Heavy growth of a single organism alongside many PMNLs on Gram stain supports that organism as the primary pathogen.
Quantitative growth: most commonly reported for urine cultures in CFU/mL. The threshold of greater than 10^5 CFU/mL of a single organism is traditionally significant for a properly collected midstream urine sample (see Topic 12 for the clinical nuances).
"No growth after 48 hours" or "Sterile" on a blood culture: the bottle was negative at the end of the incubation period. A negative blood culture does not exclude bacteraemia (sensitivity is approximately 80 to 90 per cent for a single set of two bottles from one venepuncture site, rising with additional sets).
The Susceptibility Panel
The susceptibility panel is the most action-relevant part of the report for prescribing clinicians. It shows each antibiotic tested and whether the organism is susceptible (S), susceptible at increased exposure (I, EUCAST) or intermediate (I, CLSI), or resistant (R).
Reading the panel: the antibiotic names may be given in full or as abbreviations. S means the organism is likely to be inhibited by the antibiotic at the standard dose and dosing interval, assuming a typical infection site and pharmacokinetics. I (EUCAST) means the antibiotic may still work but requires maximised pharmacokinetic exposure: higher dose, extended infusion, or site-specific concentration (for example, urine concentrations are often much higher than serum concentrations, making I-classified antibiotics clinically useful for UTI). R means the organism is not expected to respond to the antibiotic at any achievable dose.
The panel may not report all antibiotics: only antibiotics relevant to the organism and infection type are tested and reported. A susceptibility panel for E. coli from urine will include trimethoprim, nitrofurantoin, cefalexin, ciprofloxacin, co-amoxiclav. It will not include vancomycin (inactive against gram-negatives) or daptomycin (inactive against gram-negatives). If a specific antibiotic is not on the panel, contact the laboratory: additional testing can often be requested.
Interpretive Comments
Good microbiology reports include interpretive comments that contextualise the result. These comments may say: "This organism produces an ESBL. Third-generation cephalosporins should not be used despite any in vitro susceptibility." Or: "Heavy growth of CoNS from one of four blood culture bottles: likely skin contamination. Repeat blood cultures if clinically indicated." Or: "Inducible clindamycin resistance detected by D-zone test. Report as resistant."
These interpretive comments are added by the consultant microbiologist or biomedical scientist and often represent the most clinically useful single sentence on the report. They should not be ignored. If there is no comment and the result is unclear, calling the laboratory for clinical advice is entirely appropriate: microbiologists are clinicians and consultation is part of the service.
Frequently Asked Questions
What does "S" mean on a susceptibility report?
S means Susceptible: the organism is likely to be inhibited by the standard dose of this antibiotic, assuming the infection is at a typical body site and the patient has normal pharmacokinetics. In the EUCAST system, S means susceptible at standard dosing.
What does "I" mean on a susceptibility report?
In EUCAST, I means Susceptible at Increased Exposure: the antibiotic may still work, but requires maximised dosing (higher dose, extended infusion, or reliance on a body site where drug concentrates highly, such as urine). In the CLSI system, I (Intermediate) means the zone falls in a buffer range of uncertain clinical significance.
What does "R" mean on a susceptibility report?
R means Resistant: the organism is unlikely to respond to this antibiotic at any dose achievable without unacceptable toxicity. The antibiotic should not be used to treat this infection.
What does "ESBL" mean in a microbiology report comment?
ESBL (Extended-Spectrum Beta-Lactamase) means the organism produces an enzyme that destroys most penicillins and all cephalosporins. Even if cephalosporins show "S" on the susceptibility panel, they should not be used (EUCAST and CLSI guidance requires reporting ESBL-producing isolates as resistant to these agents). Carbapenems or alternative agents must be used for serious ESBL infections.
Why does a susceptibility panel sometimes not include certain antibiotics?
Susceptibility panels are tailored to the organism and likely infection site. Antibiotics not active against gram-negative bacteria (vancomycin, daptomycin) are not tested on E. coli. Antibiotics irrelevant to urine infection may not be tested on uropathogens. If a specific antibiotic is needed but not on the panel, the laboratory can usually perform additional testing on request.
What does "heavy growth" on culture mean?
Heavy growth indicates many colonies of the organism on the primary culture plate, reflecting a high bacterial load in the original sample. Combined with clinical signs of infection and an inflammatory response on Gram stain (many PMNLs), heavy growth supports the isolated organism as a true pathogen rather than a surface coloniser.
What does a culture negative CSF mean?
CSF culture negative for bacteria does not exclude: viral meningitis (culture only detects bacteria and fungi), partially treated bacterial meningitis (antibiotic-treated before lumbar puncture can sterilise CSF culture), low organism load (below the detection threshold of culture), or fastidious organisms requiring special media or prolonged incubation. CSF Gram stain, antigen tests, and PCR complement culture and improve sensitivity.
When should you call the microbiology laboratory?
Call the laboratory: when a comment on the report is unclear, when an organism you do not recognise appears on the report, when the susceptibility pattern is unusual and you need clinical interpretation, when you want to discuss whether additional tests are needed, or when you want advice on which antibiotic is most clinically appropriate given the patient's clinical situation. Microbiology laboratories offer clinical consultation as a standard part of their service.
What does "mixed growth" mean?
Mixed growth means the culture grew more than two to three different organism types, which is characteristic of surface contamination or collection of a sample from a polymicrobially colonised surface (skin, wound surface, sputum from a patient with chronic lung disease). A mixed growth result should prompt repeat sampling with careful technique if genuine infection is suspected.
Why do some blood culture reports take two or more days to arrive?
Blood culture bottles that flag positive are processed immediately for Gram stain and subculture. The Gram stain result is available within hours. Organism identification by MALDI-TOF and susceptibility testing (disc diffusion or automated broth microdilution) requires overnight incubation. Some organisms grow slowly and take 3 to 5 days to identify. Yeasts typically take 2 to 4 days. Fungi can take 2 to 6 weeks. The time to the final result reflects the time required for the organism to grow adequately for identification and susceptibility testing.